PTX-252

N/A

Report date: 2024/06/12 10:42:29
NME

Base Information

Drug NamePTX-252
Drug Alias NamePTX-252
ClassificationSmall molecules > Polymers and chelators
Mechanisms of ActionChelating agentsantioxidant
TargetsNot applicable
Therapy Area/IndicationsSmall Cell Lung CarcinomaLeukemia, Myeloid, AcuteLeukemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesPleco Therapeutics BV
China Registration ClassN/A

Develop Information

Active CompaniesHyloris Pharmaceuticals SAPleco Therapeutics BV
Inactive CompaniesN/A
Active IndicationsSmall Cell Lung CarcinomaLeukemia, Myeloid, AcuteLeukemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A